Clinical Trials Directory

Trials / Unknown

UnknownNCT02332486

Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study

Based on Metabonomics Dryness Pathogen Type of Oral Lichen Planus of Dynamic

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Heilongjiang University of Chinese Medicine · Academic / Other
Sex
All
Age
30 Years – 45 Years
Healthy volunteers
Accepted

Summary

Due to the change of life style, the incidence of oral cavity mucous membrane disease increased.In this study,been done a large number of pre-clinical practice and some experimental studies, based on the application of metabolomics technology to ultra-high liquid-mass spectrometry metabolomics analyzer as the core means, The metabolism of pattern recognition and combination of modern analytical techniques to measure blood and urine of patients with OLP-specific clearance of endogenous metabolites,and after the intervention of moss drink endogenous metabolites in the body as a whole group of. At the same time, the use of flow cytometry,,ELISA, immunohistochemistry and other modern technology, research OLP patients using clean moss drink before and after treatment of local lesions and peripheral blood CD4 +,CD8 + lymphocytes,Th1 cytokines (IFN-γ, TNF-α), Th2 cytokines (IL-4,10) the dynamic changes. From metabolomics, cellular immunology, inflammation mechanism perspective of local OLP lesions, peripheral blood and changes in endogenous metabolites in the process,,in-depth study of traditional Chinese medicine to drink clean moss multi-component multi-target treatment of this disease mechanism, is widely used in traditional Chinese medicine treatment of OLP provide a theoretical basis for the promotion of Chinese medicine Qingxian Yin in the oral mucosal disease in the application, effectively solve clinical practice problems.

Conditions

Interventions

TypeNameDescription
DRUGQingxuan DecoctionIn Qingxuan Decoction, there are a bag of Chinese honeylocust spine,Glehnia littoralis and Smilax china L,and two bags of Silktree albizia bark, Kadsura interior,Cortex dictamni, Lilium brownii var, Silkworm larva,Forsythia suspensa and Rhizoma polygonati preparata, and three bags of viridulumArisaema erubescens and Poria cocos Wolf. All drugs are made by Jiangyin Tianjiang company in China.

Timeline

Start date
2015-01-01
Primary completion
2017-12-01
First posted
2015-01-06
Last updated
2015-01-06

Source: ClinicalTrials.gov record NCT02332486. Inclusion in this directory is not an endorsement.